Antibiotic Cement Bead Pouch Versus Negative Pressure Wound Therapy
Launched by UNIVERSITY OF MARYLAND, BALTIMORE · Nov 7, 2022
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
The Beads vs Vac trial is a clinical study looking at two different ways to manage severe open tibia fractures, which are serious injuries to the shinbone that may require multiple surgeries to clean and treat. This trial involves 312 participants who will be randomly assigned to receive either an antibiotic bead pouch, which helps prevent infection, or negative pressure wound therapy (NPWT), which helps heal wounds by applying gentle suction. Researchers will follow the participants for six months after their surgeries to see how well each treatment works, with key factors including overall health, risk of amputation, need for further surgeries, and how well the fracture heals.
To be eligible for this trial, participants must be at least 18 years old with a severe open tibia fracture that needs more than one cleaning surgery. They should also have a plan for fixing the fracture in the future and must have had initial surgery within 72 hours of their injury. People who have certain medical conditions, have had previous surgeries for their fracture elsewhere, or are pregnant are not eligible. Those who join the trial can expect regular follow-ups at 6 weeks, 3 months, and 6 months to assess their recovery and the effectiveness of the treatments.
Gender
ALL
Eligibility criteria
- The inclusion criteria are:
- • 1. Patients 18 years of age or older.
- • 2. Severe open tibia fracture requiring more than one irrigation and debridement procedure to treat the open fracture.
- • 3. Planned internal or external fixation for definitive fracture management.
- • 4. Formal surgical debridement within 72 hours of their injury.
- • 5. Will have all planned fracture care surgeries performed by a participating surgeon or delegate.
- • 6. Informed consent obtained.
- The exclusion criteria are:
- • 1. Due to the severity of injury, the treating surgeon does not believe limb salvage \>6 months is likely to be successful based on the emergency department or initial intraoperative assessment (prior to enrolment and randomization).
- • 2. Medical contraindication to antibiotic beads, including previously known allergies or sensitivities to vancomycin and/or tobramycin.
- • 3. Medical or injury contraindication to NPWT. Injury contraindications could include situations in which the NPWT could not be placed over a vascular graft or exposed neurovascular structure.
- • 4. Received previous surgical debridement or management of their fracture at a non-participating hospital or clinic (as applicable).
- • 5. Chronic or acute infection at or near the fracture site at the time of initial fracture surgery.
- • 6. Incarceration.
- • 7. Women of child-bearing potential who are pregnant or intending to become pregnant within the next 6 months.
- • 8. Currently enrolled in a study that does not permit co-enrollment.
- • 9. Unable to obtain informed consent due to language barriers.
- • 10. Anticipated problems, in the judgment of research personnel, with maintaining follow-up with the patient.
- • 11. Prior enrollment in the trial.
- • 12. Other reason to exclude the patient, as approved by the Methods Center.
About University Of Maryland, Baltimore
The University of Maryland, Baltimore (UMB) is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, UMB leverages its extensive resources and expertise across various disciplines, including medicine, pharmacy, nursing, and social work, to contribute to groundbreaking discoveries and improve patient outcomes. Committed to ethical research practices and collaboration, UMB fosters an environment that promotes the translation of scientific knowledge into real-world applications, ultimately enhancing the well-being of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Los Angeles, California, United States
Madison, Wisconsin, United States
Los Angeles, California, United States
Salt Lake City, Utah, United States
Miami, Florida, United States
Indianapolis, Indiana, United States
Lebanon, New Hampshire, United States
Salt Lake City, Utah, United States
New Westminster, British Columbia, Canada
Gainesville, Florida, United States
Falls Church, Virginia, United States
Hamilton, Ontario, Canada
New Haven, Connecticut, United States
Greenville, South Carolina, United States
Cincinnati, Ohio, United States
Baltimore, Maryland, United States
Lincoln, Nebraska, United States
University, Mississippi, United States
Cincinnati, Ohio, United States
Vancouver, British Columbia, Canada
Largo, Maryland, United States
Portland, Oregon, United States
Eugene, Oregon, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials